| Name | Title | Contact Details |
|---|---|---|
Richard Manning |
Vice President/Head Patient Support Services Dupixent | Profile |
Tejdip Singh |
Senior Medical Director Clinical Research and Development | Profile |
William Bonville |
Principal Auditor R&D Site Quality Operations Gene and Cell Therapy Genomics Medicine | Profile |
Greg Hurlbut |
R&D Director/ Associate Director / Sr. Principal Scientist | Profile |
Scott Eisenbeis |
VP R&D Strategy | Profile |
Vitacorp International Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ascend Therapeutics is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics` Trilliumâ„¢ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
isotechnika is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.